Where does 2seventy bio, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), 2seventy bio, Inc. ranks #13,816 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does 2seventy bio, Inc. hold?

2seventy bio, Inc. holds 21 US utility patents granted between 2022 and 2025, spanning 9 technology areas.

What is 2seventy bio, Inc.'s Innovation Score?

2seventy bio, Inc. has an Innovation Score of 55.1 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does 2seventy bio, Inc. focus on?

2seventy bio, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 20 patents, ranking #1,122 of 7,163 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is 2seventy bio, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for 2seventy bio, Inc..

What does claim depth mean for 2seventy bio, Inc.'s patents?

2seventy bio, Inc.'s patents average 22.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the 2seventy bio, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

2seventy bio, Inc.

USPTO PatentsView assignee record - 21 granted patents across 9 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, 2seventy ranks #13,816 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 9 technology areas.

#13,816
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.1/100): 22.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R13816 · US Corporation #13,816 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 21 grants
MID-PACK #13,816/49,997
PHOTO-FINISH 1304342 Alberta
CPC-NARROW A61K · 9 areas
INNOV-PAR 55.1/100
CLAIMS-DENSE 22.9 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: 1304342 Alberta Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How 2seventy’s 55.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (19%) Velocity 20.0 pts (36%) Breadth 10.6 pts (19%) Claim depth 13.8 pts (25%)

Qualcomm Incorporated · highest

85
2seventy bio · this assignee

55
3D Lighting… · lowest

7

What this shows 2seventy's Innovation Score is 55.1/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for 2seventy?

Each dot is one of 2seventy’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). 2seventy’s own 22.9 claims/patent is ABOVE the 15.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

2seventy vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where 2seventy's grants concentrate

2seventy bio, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 95.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (7 grants) versus a trough of 6 in 2023. By volume, 2seventy sits between o9 Solutions, Inc. and A. Duda & Sons, Inc..

2seventy's three-year grant acceleration

2seventy bio, Inc. shows 19 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

o9 Solutions

22
pro med instrumen…

22
ÖHlins Racing AB

22
1304342 Alberta

21
3D Glass Solutions

21
3I

21
6 River Systems

21
A Duda & Sons

21
2seventy bio ◀

21

What this shows 2seventy holds 21 patents at rank #13,816, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 2seventy

By rank, the assignees closest to #13,816 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in 2seventy's primary technology class.

2seventy's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

2seventy bio, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	7	33.3%
2023	6	28.6%
2024	6	28.6%
2025partial year	2	9.5%

Which technologies does 2seventy bio, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 19

C07K - Peptides 19

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 19

C12Y - Enzymes 5

Y02A - Technologies FOR Adaptation TO Climate Change 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

2seventy bio, Inc.'s patent record in context - here's where to go next.

2seventy bio, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 95.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #13,816 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare 2seventy bio, Inc. against o9 Solutions, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.